Logo image of A58.DE

ELEVANCE HEALTH INC (A58.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:A58 - US0367521038 - Common Stock

320.7 EUR
+1.7 (+0.53%)
Last: 1/14/2026, 7:00:00 PM

A58.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap71.27B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Shares222.24M
Float221.87M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend5.63
Dividend Yield1.83%
EPS(TTM)26.33
PE12.18
Fwd PE13.68
Earnings (Next)01-28
IPO2001-10-30
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryManaged Health Care
A58.DE short term performance overview.The bars show the price performance of A58.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 2 4 6 8 10

A58.DE long term performance overview.The bars show the price performance of A58.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of A58.DE is 320.7 EUR. In the past month the price increased by 12.8%.

ELEVANCE HEALTH INC / A58 Daily stock chart

A58.DE Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to A58.DE.


Chartmill TA Rating
Chartmill Setup Rating

A58.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to A58.DE. There are concerns on the financial health of A58.DE while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

A58.DE Financial Highlights

Over the last trailing twelve months A58.DE reported a non-GAAP Earnings per Share(EPS) of 26.33. The EPS decreased by -11.71% compared to the year before.


Industry RankSector Rank
PM (TTM) 2.84%
ROA 4.51%
ROE 12.59%
Debt/Equity 0.71
Chartmill High Growth Momentum
EPS Q2Q%-27.96%
Sales Q2Q%10.95%
EPS 1Y (TTM)-11.71%
Revenue 1Y (TTM)11.96%

A58.DE Forecast & Estimates

28 analysts have analysed A58.DE and the average price target is 339.49 EUR. This implies a price increase of 5.86% is expected in the next year compared to the current price of 320.7.

For the next year, analysts expect an EPS growth of -8.14% and a revenue growth 13.06% for A58.DE


Analysts
Analysts73.57
Price Target339.49 (5.86%)
EPS Next Y-8.14%
Revenue Next Year13.06%

A58.DE Ownership

Ownership
Inst Owners91.68%
Ins Owners0.14%
Short Float %N/A
Short RatioN/A

About A58.DE

Company Profile

A58 logo image Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Company Info

ELEVANCE HEALTH INC

220 Virginia Avenue

Indianapolis INDIANA US

Employees: 103158

A58 Company Website

A58 Investor Relations

Phone: 18003311476

ELEVANCE HEALTH INC / A58.DE FAQ

Can you describe the business of ELEVANCE HEALTH INC?

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 103,158 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.


What is the stock price of ELEVANCE HEALTH INC today?

The current stock price of A58.DE is 320.7 EUR. The price increased by 0.53% in the last trading session.


Does A58 stock pay dividends?

ELEVANCE HEALTH INC (A58.DE) has a dividend yield of 1.83%. The yearly dividend amount is currently 5.63.


How is the ChartMill rating for ELEVANCE HEALTH INC?

A58.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Which stock exchange lists A58 stock?

A58.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the next earnings date for A58 stock?

ELEVANCE HEALTH INC (A58.DE) will report earnings on 2026-01-28, after the market close.